11
TITLE: Gene therapy approach to FAP: In vivo influence of T119M in TTR deposition in a transgenic V30M mouse model (Gene Therapy advance online publication (2014) 10.1038/gt.2014.86))
AUTHORS: Batista, AR; Gianni, D; Ventosa, M; Coelho, AV; Almeida, MR; Sena Esteves, M; Saraiva, MJ ;
PUBLISHED: 2014, SOURCE: Gene Therapy, VOLUME: 21, ISSUE: 12
INDEXED IN: Scopus
IN MY: ORCID
12
TITLE: Gene therapy approach to FAP: <i>in vivo</i> influence of T119M in TTR deposition in a transgenic V30M mouse model (vol 21, pg 1041, 2014)  Full Text
AUTHORS: Batista, AR; Gianni, D; Ventosa, M; Coelho, AV; Almeida, MR; Sena Esteves, M; Saraiva, MJ;
PUBLISHED: 2014, SOURCE: GENE THERAPY, VOLUME: 21, ISSUE: 12
INDEXED IN: WOS
IN MY: ORCID
13
TITLE: Amyloidogenic and non-amyloidogenic transthyretin Asn 90 variants  Full Text
AUTHORS: Alves, IL; Almeida, MR; Skare, J; Skinner, M; Kurose, K; Sakaki, Y; Costa, PP; Saraiva, MJM ;
PUBLISHED: 2008, SOURCE: Clinical Genetics, VOLUME: 42, ISSUE: 1
INDEXED IN: CrossRef: 7
IN MY: ORCID
14
TITLE: Effects of a new diflunisal derivative on transthyretin binding and stabilization in serum from FAP patients
AUTHORS: Almeida, MR; Macedo, B; Cardoso, I; Valencia, G; Arsequell, G; Planas, A; Saraiva, MJ ;
PUBLISHED: 2004, SOURCE: Amyloid and Amyloidosis
INDEXED IN: Scopus
IN MY: ORCID
Page 2 of 2. Total results: 14.